全球合成生物学产业正处在高速发展期，中国合成生物学产业虽然起步较晚，但发展势头强劲。本报告总结合成生物学产业发展的趋势，分析了合成生物学在生物医药、农业、食品与营养、消费个护、高性能材料、大宗化学品、生物能源等方向的应用，并对各细分行业的发展前景进行评估，旨在为相关领域的研究和实践提供有益的思考。
Education
- PhD, Yale University
- BS, Peking University
Chun Wu is the Managing Partner of BCG Greater China, leading the business in this region.
Since joining BCG, Chun has served various multinational and local healthcare clients on strategic and operational topics, covering healthcare reform impact and growth strategy; R&D, especially new technology platforms; commercial excellence and digital transformation; and organization change.
Currently, Chun dedicates significant time in big data and AI in healthcare. She also supports clients in healthcare and other industries on climate and sustainability through technology and business model innovations.
Prior to joining BCG, Chun was the co-founder and COO of iCarbonX, a healthcare big data and artificial intelligence company.
